MedTrace Logo

Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)

NCT04479488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1587

Last updated 2023-03-09

No results posted yet for this study

Summary

This is a registry-based cohort study of all adult patients (≥18 years) with confirmed or suspected SARS-CoV-2 infection.

The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients.

A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.

Conditions

  • Covid19
  • SARS-CoV Infection

Interventions

OTHER

Hospital admission

Usual care.

OTHER

Non-hospitalization procedures

Usual care.

Sponsors & Collaborators

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Otávio Berwanger, PhD · Hospital Israelita Albert Einstein

  • Henrique A Fonseca, PhD · Hospital Israelita Albert Einstein

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-27
Primary Completion
2021-03-30
Completion
2022-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04479488 on ClinicalTrials.gov